GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Holding in Top 10
Increase
Decrease
Funds Holding
2,150
Funds Holding Change
+2,150
Funds Holding Growth
–
Value
$365B
Holding in Top 10
498
Top 10 Change
+498
Top 10 Growth
–
Value Growth
–
New
2,150
Increased
–
Reduced
–
Closed
–
Capital Inflow
$380B
Capital Outflow
$0
Net Capital Flow
+$380B
Capital Flow Change
+$380B
Calls
$5.48B
Puts
$5.29B
Net Calls
+$188M
Put/Call Ratio
0.97